Skip to main content
SpringerLink
Log in
Book cover

Hormones and Cancer pp 415–444Cite as

Prostatic Growth Factors, Cancer, and Steroid Hormone Activity

  • Chapter

  • 75 Accesses

Part of the book series: Hormones in Health and Disease ((HHD))

Abstract

Several reviews on the role of peptide growth factors in the prostate were recently published (Davies and Eaton, 1991; Habib and Chisholm, 1991; Story, 1991; Steiner, 1993). Those reviews primarily focused on several of the major and most extensively studied growth factor families, including the epidermal growth factor (EGF) family, the fibroblast growth factor (FGF) family, and the transforming growth factor-β (TGF-(3) family. This chapter presents new information regarding EGF, FGF, and TGF- β, and other growth factors that have received less attention, with particular attention given to the interactions of steroid hormones and peptide growth factors.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrahamsson P-A, Alumets J, Wadstrom LB, Falkmer S, Grimelius L (1987): Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate. Prog Clin Biol Res 243A: 489–502

    Google Scholar 

  • Adlakha H, Bostwick DG (1994): Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol 25: 135–139

    Article  PubMed  CAS  Google Scholar 

  • Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE (1993): Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71: 3952–3965

    Article  PubMed  CAS  Google Scholar 

  • Arunakaran J, Aruldhas MM, Govindarajulu P (1987): Effect of prolactin and androgens on the prostate of Bonnet monkeys, Macaca radiata: 1. Nucleic acids, phosphatases, and citric acid. Prostate 10: 265–273

    Google Scholar 

  • Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL (1994): Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor (EGFR) expression. Int J Cancer 58: 721–729

    Article  PubMed  CAS  Google Scholar 

  • Baird A (1993): Fibroblast growth factors: what’s in a name? Endocrinology 132: 487–488

    Article  PubMed  CAS  Google Scholar 

  • Benbrook D, Lernhardt E, Pfahl M (1988): A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333: 669–672

    Article  PubMed  CAS  Google Scholar 

  • Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC (1988) Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrin Metab 67: 607–613

    Article  CAS  Google Scholar 

  • Bern HA (1952): Alkaline phosphatase activity in epithelial metaplasia. Cancer Res 12: 85–91

    PubMed  CAS  Google Scholar 

  • Birnbaum RS, Ware JL, Plymate SR (1994): Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrin 141: 535–540

    Article  CAS  Google Scholar 

  • Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M (1989): Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63: 1714–1720

    Article  PubMed  CAS  Google Scholar 

  • Bonkhoff H, Stein U, Remberger K (1993): Androgen receptor status in Endocrinoleparacrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virch Arch A Pathol Anat 423: 291–294

    Article  CAS  Google Scholar 

  • Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC, Jullienne A (1993): Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 53: 5076–5078

    CAS  Google Scholar 

  • Boyd D, Copestake P, Chisholm GD, Habib FK (1985): A comparison of retinol binding in human hyperplastic and malignant prostate. Br J Cancer 51: 903–905

    Article  PubMed  CAS  Google Scholar 

  • Canalis E (1992): Growth factors and their potential clinical value. J Clin Endocrin Metab 75: 1–4

    Article  CAS  Google Scholar 

  • Carmena MJ, Sancho JI, Fernandez-Gonzalez MA, Escudero F, Prieto JC (1987) Somatostatin inhibits VIP- and isoproterenol-stimulated cyclic AMP accumulation in rat prostatic epithelial cells. FEBS Lett 218: 73–76

    Article  PubMed  CAS  Google Scholar 

  • Chaproniere DM, Webber MM (1985): Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium. J Cell Physiol 122: 249–253

    Article  PubMed  CAS  Google Scholar 

  • Ching KZ, Ramsey E, Pettigrew N, D’Cunha R, Jason M, Dodd JG (1993): Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126: 151–158

    Article  PubMed  CAS  Google Scholar 

  • Cohen P, Peehl DM, Lamson G, Rosenfeld RG (1991): Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. Clin Endocrin Metab 73: 401–407

    Article  CAS  Google Scholar 

  • Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG (1992a): Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrin Metab 75: 1046–1053

    Article  CAS  Google Scholar 

  • Cohen RJ, Glezerson G, Haffejee Z (1992b): Prostate-specific antigen and prostate- specific acid phosphatase in neuroendocrine cells of prostate cancer. Arch Pathol Lab Med 116: 65–66

    PubMed  CAS  Google Scholar 

  • Cohen RJ, Glezerson G, Taylor LF, Grundle HAJ, Naude JH (1993): The neuroendocrine cell population of the human prostate gland. J Urol 150: 365–368

    PubMed  CAS  Google Scholar 

  • Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG (1994a): Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrin Metab 79: 1410–1415

    Article  CAS  Google Scholar 

  • Cohen P, Peehl DM, Graves HCB, Rosenfeld RG (1994b): Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrin 142: 407–415

    Article  CAS  Google Scholar 

  • Cohick WS, Clemmons DR (1993): The insulin-like growth factors. Annu Rev Physiol 55: 131–153

    Article  PubMed  CAS  Google Scholar 

  • Connolly JM, Rose DP (1990): Production of epidermal growth factor and transforming growth factor -a by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209–218

    Article  PubMed  CAS  Google Scholar 

  • Connolly JM, Rose DP (1991): Autocrine regulation of DU 145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173–180

    Article  PubMed  CAS  Google Scholar 

  • Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2: 467–472

    PubMed  CAS  Google Scholar 

  • Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2: 467–472

    PubMed  CAS  Google Scholar 

  • Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H (1994): Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474–5478

    PubMed  CAS  Google Scholar 

  • Cunha GR, Foster B, Donjacour A, Rubin S, Sugimura Y, Finch PW, Brody J, Aaronson SA (1994): Keratinocyte growth factor as mediator of mesenchymalepithelial interactions in the development of androgen target organs. In: Sex Hormones and Antihormones in Endrocrine Dependent Pathology: Basic and Clinical Aspects, Motta M, Serio M, eds. Amsterdam: Elsevier Science BV

    Google Scholar 

  • Cunliffe WJ, Miller AJ (1984): Retinoid Therapy. Boston: MT Press, Ltd

    Google Scholar 

  • Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P (1994): Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 59: 126–132

    Article  PubMed  CAS  Google Scholar 

  • Davies P, Eaton CL (1989): Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 14: 123–132

    Article  PubMed  CAS  Google Scholar 

  • Davies P, Eaton CL (1991): Regulation of prostate growth. J Endocrin 131: 5–17

    Article  CAS  Google Scholar 

  • de Launoit Y, Kiss R, Jossa V, Coibion M, Paridaens RJ, De Backer E, Danguy AJ, Pasteels J-L (1988) Influences of dihydrotestosterone, testosterone, estradiol, progesterone, or prolactin on the cell kinetics of human hyperplastic prostatic tissue in organ culture. Prostate 13: 143–153

    Article  PubMed  Google Scholar 

  • de Luca LM (1991): Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5: 2924–2933

    PubMed  Google Scholar 

  • de The H, Marchio A, Tiollais P, Dejean A (1989): Differential expression and ligand regulation of the retinoic acid receptor A and [3 genes. EM BO J 8: 429–433

    Google Scholar 

  • Deshpande N, Hallowes RC, Cox S, Mitchell I, Hayward S, Towler JM (1989): Divergent effects of interferons on the growth of human benign prostatic hyperplasia cells in primary culture. J Urol 141: 157–160

    PubMed  CAS  Google Scholar 

  • Di Sant’Agnese PA (1992): Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 23: 287–296

    Article  PubMed  Google Scholar 

  • Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M (1991) Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res 51: 3304–3310

    PubMed  CAS  Google Scholar 

  • Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW (1993): Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 53: 1416–1420

    PubMed  CAS  Google Scholar 

  • Dollbaum C, Creasey AA, Dairkee SH, Hiller AJ, Rudolph AR, Lin L, Vitt C, Smith HS (1988) Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc Natl Acad Sci USA 85: 4740–4744

    Article  PubMed  CAS  Google Scholar 

  • Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S (1993): Lack of the latent transforming growth factor j3 binding protein in malignant but not benign prostatic tissue. Cancer Res 53: 3193–3197

    PubMed  CAS  Google Scholar 

  • Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV (1989): Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia. Prostate 14: 191–208

    Article  PubMed  CAS  Google Scholar 

  • Fong C-J, Sherwood ER, Mendelsohn J, Lee C, Kozlowski JM (1992): Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor a. Cancer Res 52: 5887–5892

    PubMed  CAS  Google Scholar 

  • Fong C-J, Sutkowski DM, Braun EJ, Bauer KD, Sherwood ER, Lee C, Kozlowski JM (1993): Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cell. J Urol 149: 1190–1194

    PubMed  CAS  Google Scholar 

  • Fowler JE Jr, Lau JLT, Ghosh L, Mills SE, Mounzer A (1988): Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J Urol 139: 857–861

    PubMed  Google Scholar 

  • Fox SB, Persad RA, Coleman N, Day CA, Silcocks PB, Collins CC (1994): Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage Al ( Tla) prostatic adenocarcinoma. Br J Urol 74: 214–220

    Google Scholar 

  • Giguere V (1994): Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15: 61–79

    PubMed  CAS  Google Scholar 

  • Giguere V, Ong ES, Segui P, Evans RM (1987): Identification of a receptor for the morphogen retinoic acid. Nature 330: 624–629

    Article  PubMed  CAS  Google Scholar 

  • Gillespie MT, Martin TJ (1994): The parathyroid hormone-related protein gene and its expression. Mol Cell Endocrinol 100: 143–147

    Article  PubMed  CAS  Google Scholar 

  • Gleason PE, Jones JA, Regan JS, Salvas DB, Eble JN, Lamph WW, Vlahos CJ, Huang W-L, Falcone JF, Hirsch KS (1993): Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 149: 1586–1592

    PubMed  CAS  Google Scholar 

  • Glynne-Jones E, Harper ME, Goddard L, Eaton CL, Matthews PN, Griffiths K (1994): Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 25: 210–218

    Article  PubMed  CAS  Google Scholar 

  • Graham CW, Lynch JH, Djakiew D (1992): Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 147: 1444–1447

    PubMed  CAS  Google Scholar 

  • Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989): Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371

    Article  PubMed  CAS  Google Scholar 

  • Habib FK, Chisholm GD (1991): The role of growth factors in the human prostate. ScandJ Urol Nephrol Suppl 126: 53–58

    Google Scholar 

  • Halgunset J, Sunde A, Lundmo PI (1987): Retinoic acid (RA): an inhibitor of 5a-reductase in human prostatic cancer cells. J Steroid Biochem 28: 731–736

    Article  PubMed  CAS  Google Scholar 

  • Hanchette CL, Schwartz GG (1992): Geographic patterns of prostate cancer mortality. Cancer 70: 2861–2869

    Article  PubMed  CAS  Google Scholar 

  • Harper ME, Goddard L, Glynne-Jones E, Wilson DW, Price-Thomas M, Peeling WB, Griffiths K (1993): An immunocytochemical analysis of TGFa expression in benign and malignant prostatic tumors. Prostate 23: 9–23

    Article  PubMed  CAS  Google Scholar 

  • Harrison LC, Campbell IL (1988): Cytokines: an expanding network of immunoinflammatory hormones. Mol Endocrinol 2: 1151–1156

    Article  PubMed  CAS  Google Scholar 

  • Heldin C-H (1992): Structural and functional studies on platelet-derived growth factor. EMBO J 11: 4251–4259

    PubMed  CAS  Google Scholar 

  • Henttu P, Vihko P (1993): Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53: 1051–1058

    PubMed  CAS  Google Scholar 

  • Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM (1991): Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor a. Cancer Res 51: 2780–2785

    PubMed  CAS  Google Scholar 

  • Ibrahim GK, Kerns BM, MacDonald JA, Ibrahim SN, Kinney RB, Humphrey PA, Robertson CN (1993): Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol 149: 170–173

    PubMed  CAS  Google Scholar 

  • Igawa M, Tanabe T, Chodak GW, Rukstalis DB (1994): N-(4-hydroxyphenyl) retin- amide induces cell cycle specific growth inhibition in PC3 cells. Prostate 24: 299–305

    Article  PubMed  CAS  Google Scholar 

  • Iwamura M, di Sant’Agnese PA, Wu G, Benning CM, Cockett ATK, Deftos LJ, Abrahamsson P-A (1993a): Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 53: 1724–1726

    PubMed  CAS  Google Scholar 

  • Iwamura M, Sluss PM, Casamento JB, Cockett ATK (1993b): Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243–252

    Article  PubMed  CAS  Google Scholar 

  • Iwamura M, Abrahamsson P-A, Foss KA, Wu G, Cockett ATK, Deftos LJ (1994a): Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology 43: 675–679

    Article  PubMed  CAS  Google Scholar 

  • Iwamura M, Wu G, Abrahamsson P-A, di Sant’Agnese PA, Cockett ATK, Deftos LJ (1994b): Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells. Urology 43:667-674 Jacobs SC, Story MT (1988): Exocrine secretion of epidermal growth factor by the rat prostate: effect of adrenergic agents, cholinergic agents, and vasoactive intestinal peptide. Prostate 13: 79–87

    Google Scholar 

  • Jacobs SC, Story MT, Sasse J, Lawson RK (1988): Characterization of growth factors derived from the rat ventral prostate. J Urol 139: 1106–1110

    PubMed  CAS  Google Scholar 

  • Jutley JW, Kelleher J, Whelan P, Mikel J (1987): Cytosolic retinoic acid-binding protein in human prostatic dysplasia and neoplasia. Prostate 11: 127–132

    Article  PubMed  CAS  Google Scholar 

  • Jutley JK, Reaney S, Kelleher J, Whelan P (1990): Interactions of retinoic acid and androgens in human prostatic tissue. Prostate 16: 299–304

    Article  PubMed  CAS  Google Scholar 

  • Kadar T, Redding TW, Ben-David M, Schally AV (1988): Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin. Proc Natl Acad Sci USA 85: 890–894

    Article  PubMed  CAS  Google Scholar 

  • Kaicer EK, Blat C, Harel L (1991): IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 4: 231–237

    Article  PubMed  CAS  Google Scholar 

  • Kaicer EK, Blat C, Imbenotte J, Troalen F, Cussenot O, Calvo F, Harel L (1993): IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Growth Reg 3: 180–189

    CAS  Google Scholar 

  • Kim JH, Sherwood ER, Sutkowski DM, Lee C, Kozlowski JM (1991): Inhibition of prostate tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. J Urol 146: 171–176

    PubMed  CAS  Google Scholar 

  • Kingsley DM (1994): The TGF-/? superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133–146

    Article  PubMed  CAS  Google Scholar 

  • Kramer S, Reynolds FH Jr, Castillo M, Valenzuela DM, Thorikay M, Sorvillo JM (1991): Immunological identification and distribution of parathyroid hormonelike protein polypeptides in normal and malignant tissues. Endocrinology 128: 1927–1937

    Article  PubMed  CAS  Google Scholar 

  • Krijnen JLM, Janssen PJA, Riuzveld de Winter JA, van Krimpen H, Schroder FH, van der Kwast TH (1993): Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry 100: 393–398

    CAS  Google Scholar 

  • Kuhn EJ, Kurnot RA, Sesterhenn I A, Chang EH, Moul JW (1993): Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol 150: 1427–1433

    PubMed  CAS  Google Scholar 

  • Kyprianou N, Isaacs JT (1988): Identification of a cellular receptor for transforming growth factor-ß in rat ventral prostate and its negative regulation by androgens. Endocrinology 123: 2124–2131

    Article  PubMed  CAS  Google Scholar 

  • Lang SH, Miller WR, Duncan W, Habib FK (1994): Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59: 235–241

    Article  PubMed  CAS  Google Scholar 

  • Lasnitzki I (1955): The influence of a hypervitaminosis on the effect of 20-methylchol-anthrene on mouse prostate glands grown in vitro. Br J Cancer 9: 434–441

    Article  PubMed  CAS  Google Scholar 

  • Lee M-S, Garkovenko E, Yun JS, Weijerman PC, Peehl DM, Chen L-S, Rhim JS (1994): Characterization of adult human prostatic epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin- defective SV40 genome. Int J Oncol 4: 821–830

    PubMed  CAS  Google Scholar 

  • Levine AC, Ren M, Huber GK, Kirschenbaum A (1992): The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 130: 2413–2419

    Article  PubMed  CAS  Google Scholar 

  • Limonta P, Dondi D, Moretti RM, Fermo D, Garattini E, Motta M (1993): Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP. J Clin Endocrin Metab 76: 797–800

    Article  CAS  Google Scholar 

  • Limonta P, Moretti RM, Dondi D, Marelli MM, Motta M (1994): Androgen- dependent prostatic tumors: biosynthesis and possible actions of LHRH. J Steroid Biochem Mol Biol 49: 347–350

    Article  PubMed  CAS  Google Scholar 

  • Lin YC, Canatan H, Chang CJG, Hu YF, Chen R, Yu CY, Brueggemeier RW, Somers WJ (1994): Detection of keratinocyte growth factor (KGF) transcripts from normal human and archival canine benign prostatic hyperplastic tissues. J Med 25: 41–64

    PubMed  CAS  Google Scholar 

  • Liu S, Ewing MW, Anglard P, Trahan E, LaRocca RV, Myers CE, Linehan WM (1991): Effect of suramin, tumor necrosis factor and interferon gamma on human prostate carcinoma. J Urol 145: 389–392

    PubMed  CAS  Google Scholar 

  • Liu X-H, Wiley HS, Meikle AW (1993): Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-a (TGF-a) and epidermal growth factor (EGF)/TGF-a receptor. J Clin Endocrin Metab 77: 1472–1478

    Article  CAS  Google Scholar 

  • Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P (1993): Function of retinoic acid receptor c in the mouse. Cell 73: 643–658

    Article  PubMed  CAS  Google Scholar 

  • MacDonald A, Habib FK (1992): Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65: 177–182

    Article  PubMed  CAS  Google Scholar 

  • Maddy SQ, Chisholm GD, Hawkins RA, Habib FK (1987): Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocrin 113: 147–153

    Article  CAS  Google Scholar 

  • Maddy SQ, Chisholm GD, Busuttil A, Habib FK (1989): Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60: 41–44

    Article  PubMed  CAS  Google Scholar 

  • Maihle NJ, Kung H-J (1988): c-erbB and the epidermal growth factor receptor: a molecule with dual identity. Biochim Biophys Acta 948: 287–304

    Google Scholar 

  • Mansson P-E, Adams P, Kan M, McKeehan WL (1989): Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res 49: 2485–2494

    PubMed  CAS  Google Scholar 

  • Martikainen P, Kyprianou N, Isaacs JT (1990): Effect of transforming growth factor-ß1 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963–2968

    Article  PubMed  CAS  Google Scholar 

  • Matuo Y, Nishi N, Tanaka H, Sasaki I, Isaacs JT, Wada F (1988): Production of IGF-II-related peptide by an anaplastic cell line (AT-3) established from the Dunning prostatic carcinoma of rats. In Vitro 24: 1053–1060

    CAS  Google Scholar 

  • Mayarden SJ, Strom S, Ware JL (1992): Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116: 269–273

    Google Scholar 

  • McKeehan WL (1991): Growth factor receptors and prostate cell growth. Cancer Surv 11: 165–175

    PubMed  CAS  Google Scholar 

  • McKeehan WL, Adams PS (1988): Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro 24: 243–246

    CAS  Google Scholar 

  • McKeehan WL, Adams PS, Rosser MP (1984): Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44: 1998–2010

    PubMed  CAS  Google Scholar 

  • McNeal JE (1990): Pathology of benign prostatic hyperplasia: insight into etiology. J Urol Clin N Am 17: 477–486

    CAS  Google Scholar 

  • Mellon K, Thompson S, Charlton RG, Marsh C, Robinson M, Lane DP, Harris AL, Home CHW, Neal DE (1992): p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147: 496–499

    Google Scholar 

  • Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P (1992): The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 α, 25-dihydroxyvitamin D3. Cancer Res 52: 515–520

    PubMed  CAS  Google Scholar 

  • Milovanovic SR, Radulovic S, Groot K, Schally AV (1992): Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostate 20: 269–280

    Article  PubMed  CAS  Google Scholar 

  • Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M (1990): Increased expression of genes for basic fibroblast growth factor and transforming growth factor type ß2 in human benign prostatic hyperplasia. Prostate 16: 71–80

    Article  PubMed  CAS  Google Scholar 

  • Morris GL, Dodd JG (1990): Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143: 1272–1274

    PubMed  CAS  Google Scholar 

  • Muff R, Born W, Kaufmann M, Fischer JA (1994): Parathyroid hormone and parathyroid hormone-related protein receptor update. Mol Cell Endocrinol 100: 35–38

    Article  PubMed  CAS  Google Scholar 

  • Mulder E, van Loon D, de Boer W, Schuurmans ALG, Bolt J, Voorhorst MM, Kuiper GGJM, Brinkmann AO (1989): Mechanism of androgen action: recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells. J Steroid Biochem 32: 151–156

    CAS  Google Scholar 

  • Mydlo JH, Michaeli J, Heston WDW, Fair WR (1988): Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 13: 241–247

    Article  PubMed  CAS  Google Scholar 

  • Nakada SY, di Sant’Agnese PA, Moynes RA, Hiipakka RA, Liao S, Cockett ATK, Abrahamsson P-A (1993): The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Cancer Res 53: 1967–1970

    PubMed  CAS  Google Scholar 

  • Nakamoto T, Chang C, Li A, Chodak GW (1992): Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 52: 571–577

    PubMed  CAS  Google Scholar 

  • Nevalainen MT, Valve EM, Makela SI, Blauer M, Tuohimaa PJ, Harkonen PL (1991): Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinology 129: 612–622

    Article  PubMed  CAS  Google Scholar 

  • Niman HL, Thompson AMH, Yu A, Markman M, Willems JJ, Herwig KR, Habib NA, Wood CB, Houghten RIA, Lerner RA (1985): Anti-peptide antibodies detect oncogene-related proteins in urine. Proc Natl Acad Sci USA 82: 7924–7928

    Article  PubMed  CAS  Google Scholar 

  • Norman AW, Bouillon R, Thomasset M (1991): Vitamin D—Gene Regulation, Structure—Function Analysis and Clinical Application. In: Proceedings of the Eighth Workshop on Vitamin D. New York: Walter de Gruyter

    Google Scholar 

  • Okutani T, Nishi N, Kagawa Y, Takasuga H, Takenaka I, Usui T, Wada F (1991): Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells. Prostate 18: 73–80

    Article  PubMed  CAS  Google Scholar 

  • Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF (1994): Para-thyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev 15: 40–60

    CAS  Google Scholar 

  • Pastan I, Chaudhary V, Fitzgerald D (1992): Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61: 331–354

    Article  PubMed  CAS  Google Scholar 

  • Peehl DM, Rubin JS (1995): Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J Urol 13: 312–317

    PubMed  CAS  Google Scholar 

  • Peehl DM, Wong ST, Bazinet M, Stamey TA (1989): In vitro studies of human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells. Growth Factors 1: 237–250

    Article  PubMed  CAS  Google Scholar 

  • Peehl DM, Wong ST, Stamey TA (1993): Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate 23: 69–78.

    Article  PubMed  CAS  Google Scholar 

  • Peehl DM, Leung GK, Wong ST (1994a): Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 277: 11–18

    Article  PubMed  CAS  Google Scholar 

  • Peehl DM, Skowronski RJ, Feldman D (1994b): Role of vitamin D receptors in prostate cancer. In: Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects, Motta M, Serio M, eds. Amsterdam: Elsevier Science BV

    Google Scholar 

  • Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994c): Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54: 1–6

    Google Scholar 

  • Peehl DM, Cohen P, Rosenfeld RG (1995a): The insulin-like growth factor system in

    Google Scholar 

  • the prostate. World J Urol 13:306–311

    Google Scholar 

  • Peehl DM, Wong ST, Rhim JS (1995b): Altered growth regulation of prostatic epithelial cells by human papillomavirus-induced transformation. Int J Oncol 6: 1177–1184

    PubMed  CAS  Google Scholar 

  • Peehl DM, Wong ST, Rubin JS (1995c): Autocrine versus paracrine factors differentially regulate the phenotype of prostatic epithelial cells. Growth Factors 13: 306–311

    CAS  Google Scholar 

  • Perkel VS, Linkhart TA, Mohan S, Baylink DJ (1990): An inhibitory insulin-like growth factor binding protein (IN-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived IN-IGFBP. J Clin Endocrin Metab 71: 533–535

    Article  CAS  Google Scholar 

  • Pflug BR, Onoda M, Lynch JH, Djakiew D (1992): Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52: 5403–5406

    PubMed  CAS  Google Scholar 

  • Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R (1993): Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor I. Cancer Res 53: 1102–1106

    PubMed  CAS  Google Scholar 

  • Power RF, Mani SK, Codina J, Conneely OM, O’Malley BW (1991): Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636–1639

    Article  PubMed  CAS  Google Scholar 

  • Prins GS (1987): Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate. Endocrinology 120: 1457–1464

    Article  PubMed  CAS  Google Scholar 

  • Reese DH, Gordon B, Gratzner HG, Claflin AJ, Malinin TI, Block NL, Politano, VA (1983): Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphatase. Cancer Res 43: 5443–5450

    PubMed  CAS  Google Scholar 

  • Reile H, Armatis PE, Schally AV (1994): Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU 145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Prostate 25: 29–38

    Article  PubMed  CAS  Google Scholar 

  • Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifldn MD, Fisher HAG (1994): Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer 72: 3020–3028

    Article  Google Scholar 

  • Rubenstein M, Muchnik S, Dunea G, Chou P, Guinan P (1994): Inoculation of prostatic tumors with antisense oligonucleotides against mRNA encoding growth factors and receptors. In: Recent Advances in Chemotherapy, Einhorn J, Nord CE, Norrby SR, eds. Washington, DC: American Society for Microbiology

    Google Scholar 

  • Rubenstein M, Muchnik S, Dunea G, Chou P, Guinan P (1994): Inoculation of prostatic tumors with antisense oligonucleotides against mRNA encoding growth factors and receptors. In: Recent Advances in Chemotherapy, Einhorn J, Nord CE, Norrby SR, eds. Washington, DC: American Society for Microbiology

    Google Scholar 

  • Sadasivan R, Morgan R, Jennings S, Austenfeld M, van Veldhuizen P, Stephens R, Noble M (1993): Overexpression of HER-2/neu may be an indicator of poor prognosis in prostate cancer. J Urol 150: 126–131

    PubMed  CAS  Google Scholar 

  • Sanda MG, Ayyagari SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW (1994): Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151: 622–628

    PubMed  CAS  Google Scholar 

  • Schacht MJ, Niederberger CS, Garnett JE, Sensibar JA, Lee C, Grayhack JT (1992): A local direct effect of pituitary graft on growth of the lateral prostate in rats. Prostate 20: 51–58

    Article  PubMed  CAS  Google Scholar 

  • Schmid KW, Helpap B, Totsch M, Kirchmair R, Dockhorn-Dworniczak B, Bocker W, Fischer-Colbrie R (1994): Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology 24: 233–239

    Article  PubMed  CAS  Google Scholar 

  • Schuurmans ALG, Bolt J, Mulder E (1988): Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP. Prostate 12: 55–63

    Article  PubMed  CAS  Google Scholar 

  • Schwartz GG, Hulka BS (1990): Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10:1307-1312 Shah GV, Noble MJ, Austenfeld M, Weigel J, Deftos LJ, Mebust WK (1992): Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells. Prostate 21: 87–97

    Google Scholar 

  • Shah GV, Rayford W, Noble MJ, Austenfeld M, Weigel J, Vamos S, Mebust WK (1994): Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3,5-monophosphates and cytoplasmic Ca2+ transients. Endocrinology 134: 596–602

    Article  PubMed  CAS  Google Scholar 

  • Sherwood ER, Fike W, Kozlowski JM, Lee C (1988): The cytotoxic/cytostatic effect of recombinant human tumor necrosis factor alpha on experimental human prostate cancer. Proc Am Urol Assoc 139:175A, abstract 50

    Google Scholar 

  • Sherwood ER, Fong C-J, Lee C, Kozlowski JM (1992): Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 130: 2955–2963

    Article  PubMed  CAS  Google Scholar 

  • Siegall CB, Schwab G, Nordan RP, Fitzgerald DJ, Pastan I (1990): Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 50: 7786–7788

    PubMed  CAS  Google Scholar 

  • Siegsmund MJ, Yamazaki H, Pastan I (1994): Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol 151: 1396–1399

    PubMed  CAS  Google Scholar 

  • Sikes RA, Chung LWK (1992): Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res 52: 3174–3181

    PubMed  CAS  Google Scholar 

  • Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli E, Mavilio F (1990): Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells. Nature 346: 763–766

    Article  PubMed  CAS  Google Scholar 

  • Sitaras NM, Sariban E, Bravo M, Pantazis P, Antoniades HN (1988): Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. Cancer Res 48: 1930–1935

    PubMed  CAS  Google Scholar 

  • Skowronski RJ, Peehl DM, Feldman D (1993): Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952–1960

    Article  PubMed  CAS  Google Scholar 

  • Skowronski RJ, Peehl DM, Feldman D (1995): Actions of vitamin D3 analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology 136: 1–7

    Article  Google Scholar 

  • Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC (1993): Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 53: 4461–4465

    PubMed  CAS  Google Scholar 

  • Smith RG, Nag A (1987): Regulation of c-sis expression in tumors of the male reproductive tract. Prog Clin Biol Res 239: 113–122

    PubMed  CAS  Google Scholar 

  • Spriggs DR, Imamura K, Rodriguez C, Sariban E, Kufe DW (1988): Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest 81: 455–460

    Article  PubMed  CAS  Google Scholar 

  • Stadnyk AW (1994): Cytokine production by epithelial cells. FASEB J 8: 1041–1047

    PubMed  CAS  Google Scholar 

  • Stearns ME, Wang M, Fudge K (1993): Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity. Cancer Res 53: 3073–3077

    PubMed  CAS  Google Scholar 

  • Steiner MS (1993): Role of peptide growth factors in the prostate: a review Urology 42: 99–110

    Article  PubMed  CAS  Google Scholar 

  • Steiner MS, Barrack ER (1992): Expression of transforming growth factor-ß1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 6: 15–25

    Article  PubMed  CAS  Google Scholar 

  • Steiner MS, Zhou Z-Z, Tonb DC, Barrack ER (1994): Expression of transforming growth factor- ß l in prostate cancer. Endocrinology 135: 2240–2247

    Article  PubMed  CAS  Google Scholar 

  • Story MT (1991): Polypeptide modulators of prostatic growth and development. Cancer Surv 11: 123–146

    PubMed  CAS  Google Scholar 

  • Story MT, Livingston B, Baeten L, Swartz SJ, Jacobs SC, Begun FP, Lawson RK (1989): Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 15: 355–365

    Article  PubMed  CAS  Google Scholar 

  • Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK (1993): Influence of transforming growth factor ß1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 22: 183–197

    Article  PubMed  CAS  Google Scholar 

  • Sutkowski DM, Fong C-J, Sensibar J A, Rademaker AW, Sherwood ER, Kozlowski JM, Lee C (1992): Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture. Prostate 21: 133–143

    Article  PubMed  CAS  Google Scholar 

  • Syms AJ, Harper ME, Griffiths K (1985): The effect of prolactin on human BPH epithelial cell proliferation. Prostate 6: 145–153

    Article  PubMed  CAS  Google Scholar 

  • Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC (1994): Mesenchymal-epithelial interactions and transforming growth factor- ß expression during mouse prostate morphogenesis. Endocrinology 134: 1039–1045

    Article  PubMed  CAS  Google Scholar 

  • Tong P, Mayes D, Wheeler L (1986): Extracellular calcium alters the effects of retinoic acid on DNA synthesis in cultured murine keratinocytes. Biochem Biophys Res Commun 138: 483–488

    Article  PubMed  CAS  Google Scholar 

  • Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC (1993): Association of transforming growth factor-/?l with prostate cancer: an immunohistochemical study. Hum Pathol 24: 4–9

    Article  PubMed  CAS  Google Scholar 

  • Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE, Macoska JA (1994): Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 25: 199–205

    Article  PubMed  CAS  Google Scholar 

  • Varani J, Shayevitz J, Perry D, Mitra RS, Nickoloff BJ, Voorhees JJ (1990): Retinoic acid stimulation of human dermal fibroblast proliferation is dependent on sub-optimal extracellular Ca2+ concentration. Am J Pathol 136: 1275–1281

    PubMed  CAS  Google Scholar 

  • Vieweg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E (1994): Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54: 1760–1765

    PubMed  CAS  Google Scholar 

  • Vilcek J, Lee TH (1991): Tumor necrosis factor. J Biol Chem 266: 7313–7316

    PubMed  CAS  Google Scholar 

  • Vlahos CJ, Kriauciunas TD, Gleason PE, Jones JA, Eble JN, Salvas D, Falcone JF, Hirsch KS (1993): Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells. J Cell Biochem 52: 404–413

    Article  PubMed  CAS  Google Scholar 

  • Ware JL, Watts RG (1992): Isolation and characterization of transforming growth factor beta response variants from human prostatic tumor cell lines. Prostate 21: 223–237

    Article  PubMed  Google Scholar 

  • Webber MM, Perez-Ripoll EA (1986): Prolactin in the etiology and progression of human prostate carcinoma. J Urol Suppl 135: 348A

    Google Scholar 

  • Wilding G (1991): Response of prostate cancer cells to peptide growth factors: transforming growth factor- ß. Cancer Surv 11: 147–163

    Article  PubMed  CAS  Google Scholar 

  • Wilding G, Valverius E, Knabbe C, Gelman EP (1989a): Role of transforming growth factor-a in human prostate cancer cell growth. Prostate 15: 1–12

    Article  PubMed  CAS  Google Scholar 

  • Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E (1989b): Differential effects of transforming growth factor ß on human prostate cancer cells in vitro. Mol Cell Endocrinol 62: 79–87

    Article  PubMed  CAS  Google Scholar 

  • Willett WC, Hunter DJ (1994): Vitamin A and cancers of the breast, large bowel, and prostate: epidemiologic evidence. Nutr Rev 52:(II)S53–S59

    Google Scholar 

  • Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL (1992): Heparin- binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6: 2123–2128

    Article  PubMed  CAS  Google Scholar 

  • Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL (1993): Exon switching and activation of stromal and embryonic fibroblast growth factor ( FGF)—FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13: 4513–4522

    Google Scholar 

  • Yang Y, Chisholm GD, Habib FK (1993): Epidermal growth factor and transforming growth factor a concentrations in BPH and cancer of the prostate: their relation-ships with tissue androgen levels. Br J Cancer 67: 152–155

    Article  PubMed  CAS  Google Scholar 

  • Young CY-F, Murtha PE, Andrews PE, Lindzey JK, Tindall DJ (1994): Antagonism of androgen action in prostate tumor cells by retinoic acid. Prostate 25: 39–45

    Article  PubMed  CAS  Google Scholar 

  • Zhau HE, Wan DS, Zhou J, Miller GJ, von Eschenbach AC (1992): Expression of c-erbB-2/neu proto-oncogene in human prostatic cancer tissues and cell lines. Mol Carcinogen 5: 320–327

    Article  CAS  Google Scholar 

Download references

Authors
  1. Donna M. Peehl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, 1901 Perdido Street, 70112-1393, New Orleans, LA, USA

    Wayne V. Vedeckis

  2. Stanley S. Scott Cancer Center, 1901 Perdido Street, 70112-1393, New Orleans, LA, USA

    Wayne V. Vedeckis

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Birkhäuser Boston

About this chapter

Cite this chapter

Peehl, D.M. (1996). Prostatic Growth Factors, Cancer, and Steroid Hormone Activity. In: Vedeckis, W.V. (eds) Hormones and Cancer. Hormones in Health and Disease. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4266-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4266-6_15

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-8715-5

  • Online ISBN: 978-1-4612-4266-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation